LENALIDOMIDE
- Strength
- 5 mg/1
- Form
- Capsule
- Class
- Thalidomide Analog
Padagis US LLC
Listed by Sun Pharmaceutical Industries, Inc.
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Thalidomide Analog |
| Approval route | ANDA — approved generic |
| NDC code | 63304-045 |
| FDA application | ANDA211846 |
| RxNorm concept | 602910 |
| Package sizes listed | 2 |
| Marketed since | March 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Padagis US LLC
EXELAN PHARMACEUTICALS INC.
Dr. Reddy's Laboratories Inc.
Alvogen, Inc.
Aurobindo Pharma Limited
Cipla USA Inc.
Cipla USA Inc.
Mylan Pharmaceuticals Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.